{"id":"NCT02604407","sponsor":"Shire","briefTitle":"Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)","officialTitle":"A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11-19","primaryCompletion":"2016-03-24","completion":"2016-03-24","firstPosted":"2015-11-13","resultsPosted":"2017-06-14","lastUpdate":"2021-06-03"},"enrollment":275,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Attention Deficit Hyperactivity Disorder (ADHD)"],"interventions":[{"type":"DRUG","name":"SHP465 12.5mg capsules (one capsule daily)","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"SHP465 12.5mg, 25mg, or 37.5mg capsules (one capsule daily)","otherNames":[]}],"arms":[{"label":"SHP465 12.5 mg","type":"EXPERIMENTAL"},{"label":"SHP465 37.5 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The study is designed to evaluate the efficacy and safety of each dose of SHP465 (12.5 and 37.5 mg) given to participants daily in the morning compared to placebo in the treatment of adults aged 18 to 55 years diagnosed with ADHD.","primaryOutcome":{"measure":"Change From Baseline in the Adult Attention-deficit/Hyperactivity Disorder Rating Scale-4 (ADHD-RS) With Prompts Total Score at Visit 6 (Week 4)","timeFrame":"Baseline, Visit 6 (Week 4)","effectByArm":[{"arm":"Placebo","deltaMin":40.5,"sd":6.52},{"arm":"SHP465 12.5 mg","deltaMin":39.8,"sd":6.38},{"arm":"SHP465 37.5 mg","deltaMin":39.9,"sd":7.07}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":45,"countries":["United States"]},"refs":{"pmids":["28712074"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":89},"commonTop":["Decreased appetite","Dry mouth","Insomnia","Headache","Anxiety"]}}